Interactions between macrophages and T-lymphocytes: tumor sneaking through intrinsic to helper T cell dynamics.

In a mathematical model of the cellular immune response we investigate immune reactions to tumors that are introduced in various doses. The model represents macrophage T-lymphocyte interactions that generate cytotoxic macrophages and cytotoxic T-lymphocytes. In this model antigens (tumors) can induce infinitely large T-lymphocyte effector populations because effector T-lymphocytes are capable of repeated proliferation and we have omitted immunosuppression. In this (proliferative) model small doses of weakly antigenic tumors grow infinitely large (i.e. sneak through) eliciting an immune response of limited magnitude. Intermediate doses of the same tumor induce larger immune responses and are hence rejected. Large doses of the tumor break through, but their progressive growth is accompanied by a strong immune response involving extensive lymphocyte proliferation. Similarly a more antigenic tumor is rejected in intermediate doses and breaks through in large doses. Initially small doses however lead to tumor dormancy. Thus although the model is devoid of explicit regulatory mechanisms that limit the magnitude of its response (immunosuppression is such a mechanism), the immune response to large increasing tumors may either be a stable reaction of limited magnitude (experimentally known as tolerance or unresponsiveness) or a strong and ever increasing reaction. Unresponsiveness can evolve because in this model net T-lymphocyte proliferation requires the presence of a minimum number of helper T cells (i.e. a proliferation threshold). Unresponsiveness is caused by depletion of helper T cell precursors.

[1]  N. K. Jerne,et al.  Idiotypic Networks and Other Preconceived Ideas , 1984, Immunological reviews.

[2]  Z. Grossman Recognition of self, balance of growth and competition: Horizontal networks regulate immune responsiveness , 1982, European journal of immunology.

[3]  L. Old,et al.  ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS * , 1962 .

[4]  V. Riley Psychoneuroendocrine influences on immunocompetence and neoplasia. , 1981, Science.

[5]  S. Levin Lectu re Notes in Biomathematics , 1983 .

[6]  A. Basten,et al.  "Sneaking through": a T-cell-dependent phenomenon. , 1981, British Journal of Cancer.

[7]  P. Scheurich,et al.  Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. , 1982 .

[8]  P Hogeweg,et al.  Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model. , 1985, Journal of immunology.

[9]  G. Goldstein,et al.  Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36 , 1978, The Journal of experimental medicine.

[10]  J. Oxford,et al.  Immunological relationships of some oncogenic DNA viruses. I. Transplantation immunity studies. , 1969, Archiv fur die gesamte Virusforschung.

[11]  K. Kubota,et al.  Effects of age and sex of host mice on growth and differentiation of teratocarcinoma OTT6050 , 1981, Experimental Gerontology.

[12]  R. Walford,et al.  Proliferative and cytotoxic immune functions in aging mice. II. Decreased generation of specific suppressor cells in alloreactive cultures. , 1984, Journal of Immunology.

[13]  S. Rockwell Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors. , 1981, Cancer research.

[14]  M. Bevan,et al.  A differentiation factor required for the expression of cytotoxic T-cell function , 1982, Nature.

[15]  R. Miller Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. , 1984, Journal of immunology.

[16]  Z. Grossman,et al.  Tumor escape from immune elimination. , 1980, Journal of theoretical biology.

[17]  H. Macdonald,et al.  Cytolytic T lymphocytes. , 1983, Annual review of immunology.

[18]  J. Marchant Sarcoma induction in mice by methylcholanthrene. Antigenicity tests of sarcomas induced in thymus grafted and control animals. , 1969, British Journal of Cancer.

[19]  K. Lafferty,et al.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.

[20]  C. Uyttenhove,et al.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.

[21]  D. Naor Suppressor cells: permitters and promoters of malignancy? , 1979, Advances in cancer research.

[22]  M A Savageau,et al.  Network regulation of the immune response: modulation of suppressor lymphocytes by alternative signals including contrasuppression. , 1985, Journal of immunology.

[23]  R. Ullrich,et al.  Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum. , 1976, Cancer research.

[24]  P Hogeweg,et al.  Tumor escape from immune elimination: simplified precursor bound cytotoxicity models. , 1985, Journal of theoretical biology.

[25]  Z. Grossman,et al.  Recognition of Self and Regulation of Specificity at the Level of Cell Populations , 1984, Immunological reviews.

[26]  A. Sarofim,et al.  Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice. , 1980, British Journal of Cancer.

[27]  Lee A. Segel,et al.  Modeling Dynamic Phenomena in Molecular and Cellular Biology , 1984 .

[28]  D. Green,et al.  Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.

[29]  S. Swain,et al.  Mouse T-lymphocyte subpopulations: relationships between function and Lyt antigen phenotype. , 1980, Immunology today.

[30]  E. Wheelock,et al.  Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice. , 1984, Cancer Research.

[31]  K. Smith Inside the thymus. , 1984, Immunology today.

[32]  V. Usov,et al.  The nature of low-frequency cutoffs in the radio emission spectra of pulsars , 1984, Nature.

[33]  V. Schirrmacher,et al.  Correlation of “sneaking through” of tumor cells with specific immunological impairment of the host , 1975, European journal of immunology.

[34]  R. Zinkernagel,et al.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; , 1975, The Journal of experimental medicine.

[35]  M A Savageau,et al.  Network regulation of the immune response: alternative control points for suppressor modulation of effector lymphocytes. , 1985, Journal of immunology.

[36]  Mark M. Davis,et al.  Somatic recombination in a murine T-cell receptor gene , 1984, Nature.

[37]  H. Schreiber,et al.  Rescue of the tumor-specific immune response of aged mice in vitro. , 1984, Journal of immunology.

[38]  W. Paul,et al.  Regulation of B-cell growth and differentiation by soluble factors. , 1983, Annual review of immunology.